INMD News and Press, InMode Ltd. From 02/10/22

InMode Ltd. (INMD) Q4 2021 Earnings Conference Call February 10, 2022, 08:30 AM ET Company Participants Miri Segal - MS-IR Moshe Mizrahy - Chairman & CEO Shakil Lakhani - President, North America Yair Malca - CFO Spero Theodorou - CMO Conference Call Participants Matt Taylor - UBS Kyle Ro...

InMode (NASDAQ:INMD) is trading ~7% lower in the pre-market on Thursday after setting guidance in line with estimates, and the company’s Q4 2021 financials surpassed Street forecasts thanks to strong margins and the outperformance of the international segment. Fourth-qua...

InMode press release (NASDAQ:INMD): Q4 Non-GAAP EPS of $0.64 beats by $0.07. Revenue of $110.54M (+47.0% Y/Y) beats by $7M. FY22 Guidance: Revenues between $415 million and $425 million *Non-GAAP gross margin between 84% and 86% *Non-GAAP income from operations between $199 million ...

InMode Reports Record Fourth Quarter and Full Year 2021 Financial Results: Quarterly Revenue of $110.5M, 47% Year-Over-Year Growth GAAP Net Income of $52.7M, 46% Increase Compared to Q4 2020 PR Newswire YOKNEAM, Israel, Feb. 10, 2022 /PRNewswire/ -- InMode ...

InMode (NASDAQ:INMD) is scheduled to announce Q4 earnings results on Thursday, February 10th, before market open. The consensus EPS Estimate is $0.57 (-39.4% Y/Y) and the consensus Revenue Estimate is $103.54M (+37.7% Y/Y). Over the last 2 years, INMD has beaten EPS estimates 88% of the time ...

According to Verified Market Research, the global healthcare industry is worth $3.3 trillion today and could grow to $6.6 trillion by 2028. So you might want to consider having healthcare stocks in your portfolio, especially if you're a long-term investor. The good news is that these co...

Arenberg Capital initiates coverage of InMode stock with hold rating prior to the company's FY21 earnings on February 10, 2022. We ran multiple approaches to determine the fair valuation of this high-growth medtech company. Our DCF indicates a fair valuation at the current price l...

Non-fungible tokens (NFTs) are among the hottest of the ultra-speculative assets making the rounds in 2022. Everything from cartoon apes to social media posts can be minted and sold -- often to buyers with big expectations for the future value of their tokens. As cool as NFTs are, t...

When it comes to monster growth stocks in the making, it's rare to find a company that has pretty much every property an investor would want. On that note, InMode (NASDAQ: INMD) develops minimally invasive medical-aesthetics devices that can provide similar effects to laser skin tre...

The consumer healthcare market is a multi-trillion dollar industry worldwide that could double by 2028, according to Verified Market Research, which means there are opportunities to be had for patient investors. Companies delivering innovative products and services that improve patient trea...